The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. (Q51673775)
Jump to navigation
Jump to search
scientific article published on 5 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. |
scientific article published on 5 August 2010 |
Statements
1 reference
The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. (English)
1 reference
Maïté Lewin
1 reference
Laetitia Fartoux
1 reference
Alexandre Vignaud
1 reference
Lionel Arrivé
1 reference
Yves Menu
1 reference
Olivier Rosmorduc
1 reference
5 August 2010
1 reference
21
1 reference
2
1 reference
281-290
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference